4esthetics Alpha

Item #: SCP- 5001

079400550200.jpg

Front of SCP-5001

Object Class: Safe

Special Containment Procedures: SCP-5001 is to be housed in a standard Safe level object storage locker on Site-21. Due to the nature of SCP–5001, female members of SCP Foundation staff are restricted from coming into contact with it or its contents. Only male SCP Foundation staff are permitted to handle SCP–5001 or its contents. Personnel must comply with Class E safety protocols and undergo regulatory decontamination processes after testing.

Description: SCP–5001 refers to a singular can of Axe Body Spray. Image on the can resembles a blue phoenix with AXE DEODERANT SPRAY PHOENIX written on the side. Contents are standard of a name brand body spray of its type. Consisting of Aluminum Zirconium Tetracholorohydrex glycol, PPG-14 Butyl Ether, Stearyl Alcohol, PEG-8 Distearate, Hydrogenated Castor Oil, Talc, and BHT. However, this particular instance contains trace amounts of pheromones belonging to numerous as well as human DNA. The can itself has no noted properties of interest, however the liquid inside has a scent reminiscent of a typical spray deodorant. When SCP-5001 is applied to a person or object, any female humanoids within the vicinity of 4.75 meters (depending on the amount of application) of the wearer will pursue and collide with the individual wearing it. Individuals under the effect of SCP-5001 will show a complete disregard for personal safety. Attraction caused by SCP–5001 appears to be only collision based and harmful in nature. Interviews with affected subjects did not reveal the attraction to be romantic or sexual in any way. Effects of SCP–5001 appear to dissipate within 15 minutes of removal from the presence of the scent. Male subjects, either wearers or humanoids in the vicinity of SCP–5001’s scent, are unaffected in any way. Further investigation as to the distribution of SCP–5001 revealed that it was produced by British – Dutch company ████████ and marketed towards the young male demographic. The probability of other uncontained instances of SCP-5001 is unlikely. Upon inspection of the site where SCP-5001 was produced, all equipment and chemicals involved with production were seized and analyzed. Investigation into SCP-5001’s formula as well as surveillance of ████████ and its affiliates, is ongoing.

SCP-5001 was confiscated from the Siège Social Unilever Corporation in Rueil-Malmasion, France. Developed by Senior Researcher Jules Armand, SCP-5001 was intended to be working aphrodisiac formula, intended to induce attraction, specifically targeting the female gender. Testing designed to demonstrate the effectiveness of SCP-5001 resulted in several injuries which caused those under its effects to seek medical attention. Subsequent interviews with Law Enforcement prompted the attention of embedded field Agents within the city of Marseille, France. SCP-5001 was ultimately confiscated once its properties were known and all researchers and CEO’s present during SCP-5001’s demonstration were given Class-A Amnestics. All data related to SCP-5001, including formulas, testing logs, and video records were subsequently confiscated as well as analyzed.

The Emails below were confiscated from Unilver's server. Any unnecessary banter between employees has been excluded and only pertinent information concerning SCP-5001 has been included.

Human Trials

24 months and 12 days after the initial EMA request. MD-40 was granted permission to begin human trials.

Chief Executive Officer Louis Larouche

We’ve been looking into your research and I must say we are most impressed with what you’ve been able to accomplish. I am in sheer awe of the product you’ve produced. The headlines alone will put us at the top. Advertising is going to have a field day. To get things started, I’d like you to put together a demonstration for our shareholders as soon as possible. I want a viable production formula by the end of this quarter and we can start shipping as early as March, just in time for the Spring/ Summer season. Excellent work, and we look forward to seeing you soon.